MEDRAD Intego PET Infusion System - Pump Intended to deliver accurate doses of Fluoredeoxyglucos...
FDA Device Recall #Z-0927-2017 — Class II — November 7, 2016
Recall Summary
| Recall Number | Z-0927-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 7, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Bayer Healthcare |
| Location | Indianola, PA |
| Product Type | Devices |
| Quantity | 178,982 (86,172 units in U.S.) |
Product Description
MEDRAD Intego PET Infusion System - Pump Intended to deliver accurate doses of Fluoredeoxyglucose or F-Sodium Fluoride and commonly used flushing solutions to patients during molecular imaging (nuclear medicine) diagnostic procedures. It is also intended to provide effective radiation shielding to medical personnel from Fluorine-18 radiation exposure during nuclear medicine diagnostic procedures.
Reason for Recall
Bayer has determined that all current Source Administration Sets (SAS) used with the Medrad Intego Pet Infusion System may produce particulates in radiopharmaceutical (RP) vials when the needle is inserted.
Distribution Pattern
Nationwide Distribution
Lot / Code Information
Device Listing # D053816
Other Recalls from Bayer Healthcare
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0400-2017 | Class II | PET Infusion Pump | Sep 30, 2016 |
| Z-2768-2016 | Class II | Certegra Workstation used in conjunction with M... | Aug 2, 2016 |
| Z-2244-2016 | Class II | Angiographic Injector and Syringe, MEDRAD MRXpe... | Jun 9, 2016 |
| Z-0627-2016 | Class II | Medrad Source Administration Sets, Catalog numb... | Nov 30, 2015 |
| Z-2775-2015 | Class II | Angiographic Injector. Medrad Mark 7 Arterion I... | Aug 4, 2015 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.